Defeat Cancer from Within
Pioneering a new class of precision therapeutics to overcome immunosuppression and bolster the immune system's power to fight cancer.
Defeat Cancer
from Within
Pioneering a new class of precision therapeutics to overcome immunosuppression and bolster the immune system’s power to fight cancer.
With Cancer, It’s Personal
Tumors employ clever strategies to outwit the body’s immune system. To survive, they develop various ways of avoiding detection or inhibiting anticancer immune activity, allowing them to grow and spread.
Through our own journey with cancer and our deep understanding of immuno-oncology, we know that every tumor is different. Successful therapy requires a tailored and targeted approach to ensure effective anti-tumor immune surveillance and to overcome immunosuppressive barriers.
At Angarus, we are developing a new class of therapeutics that selectively target immune-activating and immunosuppressive pathways within the tumor microenvironment. We use predictive biomarkers for a more powerful, precise, and coordinated attack against cancer.
The Most Formidable Tool Against Cancer Comes from Within
Unraveling the complexities of immune-surveillance and immunosuppressive pathways and the associated molecular targets is not an easy task. In collaboration with scientists from Stanford University, our efforts have enabled the discovery of highly specific therapeutic candidates and key predictive biomarkers that can make precision immunotherapy a reality. We are driven to find a better way to defeat cancer by optimizing immunotherapy.